An Echelon Media Company
Sunday June 13th, 2021
All Sections
Notable
Japan's Takeda Pharmaceutical Company Limited (Takeda) on Wednesday said its trials on the dengue vaccine candidate (TAK-003), including in Sri Lanka,...
4 minutes
Japan's Takeda Pharmaceutical Company Limited (Takeda) on Wednesday said its trials on the dengue vaccine candidate (TAK-003), includin...
2 min read
Japan's Takeda Pharmaceutical Company Limited (Takeda) on Wednesday said its trials on the dengue vaccine candidate (TAK-003), including in Sri Lanka,...
2 min read
Japan's Takeda Pharmaceutical Company Limited (Takeda) on Wednesday said its trials on the dengue vaccine candidate (TAK-003), including in Sri Lanka,...
2 min read
Japan's Takeda Pharmaceutical Company Limited (Takeda) on Wednesday said its trials on the dengue vaccine candidate (TAK-003), including in Sri Lanka,...
Japan's Takeda Pharmaceutical Company Limited (Takeda) on Wednesday said its trials on the dengue vaccine candidate (TAK-003), including in Sri Lanka,...
| Latest | Last | |
|---|---|---|
| US Dollar | 199.7609 | 199.6761 |
| UK Pound | 283.0512 | 281.9227 |
| Euro | 243.3887 | 242.9958 |
| Aus Dollar | 154.7448 | 154.3596 |
| Yen | 1.8259 | 1.8257 |
| Latest | Last | |
|---|---|---|
| Indian Rupee | 2.7358 | 2.7359 |
| Korea Won | 0.1797 | 0.1792 |
| Oman Rial | 518.8730 | 518.6527 |
| Saudi Riyal | 53.2540 | 53.2313 |
| UAE Dirham | 54.3841 | 54.3610 |
| pts | % | |
|---|---|---|
| S&P SL20 | 3,074.10 | 1.04% |
| CSE All Share | 7,601.16 | 0.49% |
| Turnover Rs million. | 3,227,216 |
| Latest | Last | |
|---|---|---|
| 3-m bill | 5.06 | 5.06 |
| 6-m bill | 5.11 | 5.10 |
| 12-m bill | 5.16 | 5.16 |
| 5-yr bond | 7.31 | 7.31 |
| 8-yr bond | 7.85 | 7.61 |
| today | yesterday | |
|---|---|---|
| Overnight Money | 4.67 | 4.67 |
| Gilt Repo | 4.68 | 4.68 |
| I-m SLIBOR | - | - |
Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement (updated 1/1/20) and Privacy Policy and Cookie Statement (updated 1/1/20). Your California Privacy Rights. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Condé Nast. Ad Choices.
Gain clarity on the biggest stories of the day with our daily newsletter, Morning Briefing
© 2021 Echelon Media (PVT) Ltd. All Rights Reserved
2 min read